Gossamer Bio to Announce Fourth Quarter and Full-Year 2020 Financial Results and Host Conference Call and Webcast on February 25, 2021

Rhea-AI Summary

Gossamer Bio, a clinical-stage biopharmaceutical company (Nasdaq: GOSS), announced it will report its fourth quarter and full-year 2020 financial results on February 25, 2021. A conference call and webcast will follow at 8:30 a.m. ET that same day, providing an update on the financial results and corporate developments. Investors can access the live webcast via the company's website. Gossamer Bio is dedicated to developing therapeutics in immunology, inflammation, and oncology, aiming to become a leader in these fields.

Positive

• Upcoming financial results may indicate growth and corporate progress.

Negative

• None.

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced that it will report its fourth quarter and full-year 2020 financial results on Thursday, February 25, 2021.

In connection with the earnings release, Gossamer’s management team will host a live conference call and webcast at 8:30 a.m. ET on Thursday, February 25, 2021, to discuss the Company’s financial results and provide a corporate update.

Conference ID: 5764004
Domestic Dial-in Number: (833) 646-0603
International Dial-in Number: (929) 517-9782
Live Webcast: https://edge.media-server.com/mmc/p/vsbk8uqe

A replay of the audio webcast will be available for 30 days on the Investors section of the Company's website, www.gossamerbio.com.

About Gossamer Bio

Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210219005072/en/

FAQ

When will Gossamer Bio report its Q4 2020 earnings?

Gossamer Bio will report its Q4 2020 earnings on February 25, 2021.

What time is the Gossamer Bio conference call?

The Gossamer Bio conference call is scheduled for 8:30 a.m. ET on February 25, 2021.

How can I access the Gossamer Bio earnings webcast?

You can access the Gossamer Bio earnings webcast via their website.

What is the focus of Gossamer Bio?

Gossamer Bio focuses on developing therapeutics in immunology, inflammation, and oncology.